Picture of TruTrace Technologies logo

TTT TruTrace Technologies Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for TruTrace Technologies, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.

2018
March 31st
2019
April 30th
2020
April 30th
2021
April 30th
2022
April 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00.010.4030.1630.118
Cost of Revenue
Gross Profit-0.0550.398
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses0.3514.84.941.761.79
Operating Profit-0.35-14.7-4.54-1.6-1.67
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.346-14.8-4.64-1.62-2.33
Net Income After Taxes-0.346-14.8-4.64-1.62-2.33
Net Income Before Extraordinary Items
Net Income-0.346-14.8-4.64-1.62-2.33
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.346-14.8-4.64-1.62-2.33
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.094-0.157-0.055-0.014-0.014